Allergan Aesthetics Illuminates Latest Scientific Innovations at AMWC Dubai

Allergan Aesthetics, the aesthetics branch of AbbVie, has been at the forefront of aesthetic science and innovation. At the upcoming Aesthetic Anti-Aging Medicine World Congress (AMWC) in Dubai, taking place from October 21-23, 2026, the company will present a wealth of scientific research and educational opportunities revolving around its expanding aesthetic portfolio. This year's focus is particularly on HArmonyCa™, a revolutionary hybrid injectable that blends hyaluronic acid (HA) and calcium hydroxyapatite (CaHA), marking an important advancement in regenerating aesthetics.

Key Presentations and Discussions

During the conference, Allergan Aesthetics will present eight scientific posters featuring long-term data across its flagship products, including HArmonyCa™, JUVÉDERM®, SKINVIVE™, and BOTOX® Cosmetic. The latest findings emphasize HArmonyCa™'s dual-action technology, which provides both immediate and lasting improvements in facial volume and structure, particularly important for individuals undergoing medical weight loss.

Notably, the program includes an expert-led symposium conducted by the Allergan Medical Institute (AMI) that will delve into the AA Signature™ approach, which focuses on personalized treatment that considers the individual needs of patients. With a strong team of global faculty, discussions will explore how to leverage clinical evidence to enhance treatment plans effectively.